# Andreas L. Birkenfeld

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andreas-l-birkenfeld/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,404 |
| Field | Diabetes Treatment and Management |
| h-index | 63 |
| i10-index | 226 |
| Last Known Institution | King's College London |
| OpenAlex ID | https://openalex.org/A5013839934 |
| ORCID iD | https://orcid.org/0000-0003-1407-9023 |
| Works | 613 |

## Researcher papers

- [Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/oral-semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Practical recommendations for the management of diabetes in patients with COVID-19](https://scholariq.org/papers/practical-recommendations-for-the-management-of-diabetes-in-patients-with-covid/)
- [Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial](https://scholariq.org/papers/efficacy-and-safety-of-semaglutide-compared-with-liraglutide-and-placebo-for/)
- [Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial](https://scholariq.org/papers/early-detection-of-diabetic-kidney-disease-by-urinary-proteomics-and-subsequent/)
- [Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial](https://scholariq.org/papers/efficacy-and-safety-of-dapagliflozin-in-patients-with-inadequately-controlled-2/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [King's College London](https://scholariq.org/institutions/king-s-college-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.